CARBONIC
MOLECULAR TARGETCarbonic anhydrase 12 (human)
CARBONIC (Carbonic anhydrase 12 (human)) is targeted by 17 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CARBONIC
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Celecoxib | 1.79 | 5 |
| 2 | Furosemide | 1.39 | 3 |
| 3 | Indapamide | 1.39 | 3 |
| 4 | Mafenide | 1.39 | 3 |
| 5 | Sulpiride | 1.39 | 3 |
| 6 | benzolamide | 1.10 | 2 |
| 7 | Histamine | 1.10 | 2 |
| 8 | Metolazone | 1.10 | 2 |
| 9 | Sulfanilamide | 1.10 | 2 |
| 10 | Bumetanide | 0.69 | 1 |
| 11 | Chlorthalidone | 0.69 | 1 |
| 12 | Lacosamide | 0.69 | 1 |
| 13 | Pioglitazone | 0.69 | 1 |
| 14 | Sorafenib | 0.69 | 1 |
| 15 | stx64 | 0.69 | 1 |
| 16 | Troglitazone | 0.69 | 1 |
| 17 | Zonisamide | 0.69 | 1 |
About CARBONIC as a Drug Target
CARBONIC (Carbonic anhydrase 12 (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 17 compounds with documented CARBONIC interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CARBONIC inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.